August 8, 2013 (San Diego) – There have been many breakthroughs recently in the study of adult (non-embryonic) stem cells. But the national media has all but ignored them. Most news outlets still seem to prefer perpetuating the tired notion that all adult stem cell researchers are cons and all patients who enroll in adult stem cell clinical trials are fools. That's no longer the case.
Yes, there are still unethical players in this sector who take advantage of ailing, desperate patients willing to try anything. And yes, this is a relatively new field about which there is still much to learn. But a number of reputable companies that specialize in this research, including Medistem and Cytori Therapeutics, already have FDA-approved trials under way or in the pipeline for a variety of health conditions.